Drugs
CAMBRIDGE, MA: CAMBRIDGE, MA -- (Marketwire) -- 03/04/13 -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, today announced positive results from a non-human primate stu ...
LYON, FRANCE: Conference Call With Management to Take Place at 8:30 AM EST on February 28, 2013 ...
SANTA ANA, CA: SANTA ANA, CA -- (Marketwire) -- 02/26/13 -- Io Therapeutics, Inc. announced today the initiation of a collaboration with The Michael J. Fox Foundation for Parkinson's Research (MJFF) to evaluat ...
FOSTER CITY, CA: Restatement Is Expected to Increase 2012 Earnings Before Income Taxes by Approximately $2 Million and to Decrease 2011 Earnings Before Income Taxes by Less Than $1 Million ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 02/22/13 -- Sirona Biochem Corp. (TSX VENTURE: SBM)(OTCQX: SRBCF)(FRANKFURT: ZSB), (the "Company") announced today a non-brokered private pla ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 02/21/13 -- Xylitol Canada Inc. ("Xylitol Canada", or the "Company") (TSX VENTURE: XYL) is pleased to announce that Mr. Horst Hueniken has bee ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 02/21/13 -- Theravance, Inc. (NASDAQ: THRX) announced today that Michael W. Aguiar, Theravance's Senior Vice President and Chief Financial Officer, is ...
MENLO PARK, CA: MENLO PARK, CA -- (Marketwire) -- 02/19/13 -- AntriaBio, Inc. (OTCQB: ANTB) is pleased to announce the appointment, on January 31, 2013, of two new members to its management team: Nevan Elam, as Antr ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 02/13/13 -- Theravance, Inc. (NASDAQ: THRX) announced today that Rick E Winningham, Theravance's Chief Executive Officer, is scheduled to present at th ...
CAMBRIDGE, MA: Addresses Industry Demand for Advanced Approaches for Complex Biologics Characterization ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 02/12/13 -- Theravance, Inc. (NASDAQ: THRX) (the "Company") reported today its financial results for the fourth quarter and full year ended Decemb ...
MENLO PARK, CA: MENLO PARK, CA -- (Marketwire) -- 02/08/13 -- AntriaBio, Inc. ("AntriaBio") today announced that FINRA has approved a change of the Company's stock ticker symbol. Effective today, the ...
LYON, FRANCE: Announces Appointment of Gregg Stetsko as Vice President, Research & Development ...
MENLO PARK, CA: MENLO PARK, CA -- (Marketwire) -- 02/06/13 -- AntriaBio Delaware, Inc. f/k/a AntriaBio, Inc. ("AntriaBio Delaware") (OTCQB: FMYY), a biopharmaceutical company developing novel therapeutics ...
KIRKLAND, QUEBEC: Incontinence Fellowship application deadline is April 1, 2013 ...
FOSTER CITY, CA: FOSTER CITY, CA -- (Marketwire) -- 02/04/13 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Friedhelm Blobel, Ph.D., Chief Executive Officer, will present a corporate overview a ...
BEVERLY, MA: BEVERLY, MA -- (Marketwire) -- 02/04/13 -- Cellceutix Corporation (OTCBB: CTIX) (the "Company"), a clinical stage biopharmaceutical company focused on discovering small molecule drugs to tr ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 01/31/13 -- Biologix Hair Inc. (OTCBB: BLGX) (OTCQB: BLGX) has appointed Thomas M. McDermott to Chair its Board of Directors, replacing Ron Holland who will remain ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 01/30/13 -- Biologix Hair Inc. (OTCBB: BLGX) (OTCQB: BLGX) has appointed Thomas M. McDermott to Chair its Board of Directors, replacing Ron Holland who will remain ...
FOSTER CITY, CA: FOSTER CITY, CA -- (Marketwire) -- 01/30/13 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that it has successfully negotiated renewals of its exclusive product promotion agreement ...
